Forest Laboratories, Inc. (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people's lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest's current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The Company is headquartered in New York, NY.

Publications 78 show all

  • 8
    Models, Statistical
  • 4
    Citalopram/pharmacokinetics
  • 4
    Data Interpretation, Statistical
  • 4
    Pulmonary Disease, Chronic Obstructive/drug therapy
  • 3
    Aminopyridines/therapeutic use
  • 3
    Antidepressive Agents, Second-Generation/pharmacokinetics
  • 3
    Benzamides/therapeutic use
  • 3
    Clinical Trials as Topic/methods
  • 3
    Fluocinolone Acetonide/analogs & derivatives
  • 3
    Pneumonia, Bacterial/drug therapy

Patents 476show all

  • 265
    A61K - Preparations for medical, dental, or toilet purposes
  • 47
    C07D - Heterocyclic compounds
  • 21
    C07C - Acyclic or carbocyclic compounds
  • 16
    Y02A - Technologies for adaptation to climate change
  • 12
    C07K - Peptides
  • 11
    C07H - Sugars
  • 8
    C07B - General methods of organic chemistry
  • 6
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 4
    B65D - Containers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers
  • 4
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Clinical Trials 351show all

125Phase 3108Phase 447Phase 230N/A18Phase 114Other

SEC Filings show all


110
8-K

62
10-Q

22
10-K

Contact Information

909 Third Avenue
New York, NY 10022
United States

Overview

Total FundingEmployeesLast Funding DateStatus
5001-10000Acquired